Omeros reported $-24016000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acelrx Pharmaceuticals ACRX:US $ -10015000 873K
Adamas Pharmaceuticals ADMS:US -9155000 370K
Adma Biologics ADMA:US $ -15.58M 0.42M
Aerie Pharmaceuticals AERI:US $ -31.5M 2.72M
Alexion Pharmaceuticals ALXN:US $ 636.2M 14.1M
Alnylam Pharmaceuticals ALNY:US $ -146.16M 40.09M
Biomarin Pharmaceutical BMRN:US $ 11.67M 13.41M
Cytokinetics CYTK:US $ -54.8M 14.19M
Dynavax Technologies DVAX:US $ 3.94M 24.59M
Gilead Sciences GILD:US $ 2246M 644M
Heron Therapeutics HRTX:US $ -60.47M 8.36M
Insmed INSM:US $ -106255000 22.42M
Intercept Pharmaceuticals ICPT:US $ 0.76M 30.11M
Knight Therapeutics Inc GUD:CN C$ 198K 2.49M
Macrogenics MGNX:US $ -40279000 11.01M
Mirati Therapeutics MRTX:US $ -164.19M 31.76M
Omeros OMER:US $ -24016000 6.6M
Pacira Pharmaceuticals PCRX:US $ 34.84M 15.41M
Pfizer PFE:US $ 5914M 397M
Regulus Therapeutics RGLS:US $ -6.64M 0.84M
Rockwell Medical RMTI:US $ -7.82M 0.64M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Sarepta Therapeutics SRPT:US $ -167.57M 15.71M
United Therapeutics UTHR:US $ 219.9M 284.7M
Vertex Pharmaceuticals VRTX:US $ -37.96M 925.79M
Vital Therapies VTL:US $ -19.17M 13.22M
Xoma XOMA:US $ -3364000 3.06M